NASDAQ:KRTX

Karuna Therapeutics, Inc Earning Date

USA |NASDAQ |USD

KRTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-1.44 $-1.17 $-0.71
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $0.00 $0.00 $0.00

Karuna Therapeutics, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

KRTX Earnings Date & History Chart

KRTX Earnings & Revenue Forecast

KRTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 15 $-1.69 $-2.50 $-1.26
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 16 $-5.49 $-6.68 $-4.84
Dec 2022 16 $-6.45 $-9.07 $-4.72

KRTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.71 $-1.73 $-1.69
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-5.53 $-5.56 $-5.80
Dec 2022 0 / 0 $-6.47 $-6.48 $-6.30

KRTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 12 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $0.00 $0.00 $0.00
Dec 2022 14 $0.00 $0.00 $0.00

KRTX Earnings Date & Revenue History

KRTX Earnings History

|
Show More
Show More

KRTX Revenue History

|
Show More
Show More

Karuna Therapeutics, Inc Next Earnings Date & Report

KRTX Next Earnings Date & Report Preview: Sep 2021 (FQ)

KRTX's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 15 analysts, the average EPS estimation for Karuna Therapeutics, Inc's next quarterly earnings is $-1.44, with a low EPS estimation of $-1.70, and a high estimation of $-1.22.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.45, the last 2 month trend is $-1.46, and the 3 month trend is $-1.53.

Based on 11 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Karuna Therapeutics, Inc Previous Earnings Dates & Reports

KRTX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Karuna Therapeutics, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

KRTX's earnings per share (EPS) was $-1.17, beating the consensus analysts forecast of $-1.40 by 16.68%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 6.36%, and lower than the same period a year before (Jun 2020) by 80.00%.

Revenues were $0.00.

The company reported a net income of $-34.42M.

Free cash flow for the quarter was $-29.63M , compared to $-21.23M last quarter and $-15.95M a year before.

KRTX ended the quarter with $8.40M in total debt, an increase of 238.71% compared to the previous quarter, and an increase of 220.86% compared to the same quarter a year before.

KRTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Karuna Therapeutics, Inc's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

KRTX's earnings per share (EPS) was $-2.58, beating the consensus analysts forecast of $-2.59 by -0.39% , and lower than the previous year's EPS (Dec 2019) by 38.71%.

Revenues were $0.00.

The company reported a net income of $-68.55M.

Karuna Therapeutics, Inc reported a free cash flow of $-70.28M for its fiscal year, compared to $-31.04M a year ago.

The company ended the fiscal year with $2.69M in total debt, an increase of 1190.87% compared to the previous year.